An antibodylike paraprotein has been isolated from a patient with multiple myeloma and autoimmune hyperlipoproteinemia.
Introduction
The occurrence of hyperlipidemia accompanied by circulating immunoglobulins reactive against plasma lipoproteins has been observed most frequently, but not exclusively, in multiple myeloma. The concept of an autoimmune hyperlipidemia was Receivedfor publication 27 August 1984 and in revisedform 11 March 1985. proposed by Beaumont and Beaumont to explain this phenomenon (1) , and numerous examples have been reported (2) (3) (4) (5) , with either IgG-or IgA-immunoreactive paraproteins predominating. The mechanisms of these diseases are becoming better understood and appear to involve a balance involving variable inhibition of the normal lipoprotein catabolic pathways, removal of lipoprotein immune complexes by macrophagemediated processes or via the bile, and compensatory acceleration of cellular lipoprotein synthesis and secretion (5) (6) (7) (8) (9) (10) (11) . Hyperlipidemia may also occur in the presence of a circulating immunoglobulin which binds heparin, thus blocking activation of lipoprotein lipase (9) .
This report concerns a subject with autoimmune hyperlipidemia, associated with an IgA myeloma, whose lipoprotein immune complexes formed aggregates that comprised -20% of the blood volume and were thought to constitute the globules visible in the retinal circulation. We report the characterization of the circulating paraprotein and describe its immunoreactivity with specific apolipoproteins.
Clinical summary
A 74-yr-old man with a 10-yr history of elevated cholesterol was diagnosed 2 yr previously as having a plasma cell myeloma with extensive bone marrow infiltration. Serum protein electrophoresis revealed a monoclonal spike and serum IgA was elevated to 2,720 mg/dl; IgG and IgM were normal. The serum cholesterol was 1,370 mg/dl and triglycerides 3,620 mg/dl. He was not diabetic and had no symptoms of ischemic heart disease. The patient was treated with alkeran and prednisone with an apparent good response, his cholesterol and triglycerides falling to 150 and 457 mg/dl. 4 d before the patient was first seen at The Shand's Hospital of the University of Florida, Gainesville, FL, he had developed lower extremity weakness with bladder incontinence, and his mental status had begun to deteriorate. On admission the patient was lethargic but arousable. He had no xanthomas, arcus cornea, or evidence of retinal lipid deposits. A striking finding on ophthalmoscopic examination of the retinal vessels was the presence of many discrete, white globules flowing rapidly through the arteries and veins (Fig. 1 ). There were no hemorrhages or exudates. Cardiovascular exam was positive for bruits in the left carotid and bilateral femoral arteries but with good peripheral pulses. The liver and spleen were not enlarged. Neurologically he was oriented only to person and place, and there was diffuse weakness of the distal muscles in the legs with asymmetric tendon reflexes and negative Babinski reflexes. During the next several days he lapsed into unconsciousness.
The important laboratory findings were in the blood. As venous blood was drawn into a syringe it flowed in mottled patterns of white, pink, and red. Upon low-speed centrifugation blood separated into three layers: red cells, clear plasma, and at the top of the tube, a congealed mass of white lipid which would not disperse upon mixing (Fig. 2) . This lipid coagulum comprised '20% of the blood volume. Total plasma triglycerides measured -3,500 and cholesterol 800 mg/dl. The coagulum-free plasma had triglyceride and cholesterol concentrations of 396 and 85 mg/dl, respectively, and immunoglobulin quantitation revealed IgA 1,118 mg/dl, IgG 270 mg/dl, and IgM 21 mg/dl. The plasma creatinine and liver function parameters were normal.
On the assumption that lipoprotein aggregates were producing a hyperviscous blood, plasmaphereses were performed over several days followed by reinstitution of alkeran and prednisone. The patient sustained a drop in the volume of his plasma lipid coagulum to <10% with a gradual return to a normal mental status; however, his lower extremity paralysis and neurogenic bladder persisted and was thought to be the result of a spinal cord infarction.
A description of the isolation and characterization of the immune complexes follows.
Methods
Large and small very low density, intermediate density, low density, and high density lipoproteins (VLDL, IDL, LDL, and HDL)I were isolated from human plasma by sequential differential-density ultracentrifugation as described ( 12). LDL was delipidated by ether/ethanol 1. Abbreviations used in this paper: apo, apolipoprotein; apo B, apolipoprotein B, the major protein component of low density lipoproteins; apo A, apo C, apo E, apo A-I, apo A-II, apo C-II, and apo C-III, apolipoproteins A, C, E, A-I, A-II, C-lI, and C-Ill; HDL, HDL isolated at 1.06 < d < 1.21 g/ml; IDL isolated at 1.006 < d < 1.02 g/ ml; LDL isolated at 1.02 < d < 1.06 g/ml; Sie IgA-C, IgA paraprotein recovered from the coagulum; Sie IgA-P, IgA paraprotein recovered from the plasma. extraction in the presence of 6 M guanidine as described (13) , and apolipoprotein B (apo B) was made soluble in 10 mM Tris by the method of Cardin et al. (14) . Homogeneity of the myeloma paraprotein and of apo B was assessed by SDS-polyacrylamide gel electrophoresis (15) . Protein concentrations were determined by a modification of the method of Lowry (17) .
Preparation of apolipoproteins. The lipoprotein fraction isolated from the IgA/lipoprotein coagulum at a density of 1.20 g/ml was delipidated by either tetramethyl urea or ether/ethanol extraction, and the apolipoproteins that remained soluble were examined by 7 .5% polyacrylamide gel electrophoresis in the presence of 10 M urea (18) or by isoelectric focusing in the presence of 6 M urea using pH [4] [5] [6] ampholytes (Bio-Rad Laboratories, Richmond, CA). The insoluble apoprotein fraction was resolubilized in 3% SDS and examined on 4% polyacrylamide/SDS gels (15) .
Apolipoproteins were isolated from normal human plasma. Apo B, in a soluble state was prepared from LDL by the method of Cardin et al. (14) . Apolipoproteins apo A-I and apo A-II were prepared from HDL and apo C and apo E from VLDL by ethanol/diethylether delipidation in a 0.1 M Tris, pH 8 buffer containing guanidine-HCI, 3 or 6 M, respectively. The proteins were then isolated in the same Tris buffer but with 6 M urea using, respectively, either Sephacryl S-200 or Sepharose CL-6B columns, and the purity ofthe proteins was determined by polyacrylamide gel electrophoresis (18) . Apolipoproteins from VLDL and HDL were also purified directly from polyacrylamide gels by electrophoretic elution as recently described (19 specifically.
The influence of the nonionic detergent Triton X-100 (Sigma Chemical Co.) on the reactivity of Sie IgA with '251I-LDL was assessed by measuring the formation of precipitable immune complex in the presence of varying concentrations of Triton. Specifically, a 200-i1 aliquot containing -6,000 ng of Sie IgA-C was added to 100 ul of diluted Triton X-100, and followed by 70 Ml containing 50 ng of 1251I LDL and 5 ul of lipoprotein-free human plasma. Final Triton X-100 dilutions ranged from 0.002% to 0.2%. The samples were incubated for 72 h, anti-human IgA was added, and they were processed as outlined above. The results were plotted as (B -B,)/(TC -B,.,) vs. % Triton X-100.
To examine in greater detail how Triton X-100 alters the interaction of Sie IgA with '25l-LDL, samples of each reactant were incubated with 0.2% Triton X-100 at 4°C overnight. Triton treated Sie IgA-C was then titrated against untreated '25I-LDL in the 2% BSA/Tris buffer as outlined above, or untreated Sie IgA was titrated against Triton treated '251-LDL. In either case the final concentrations of Triton X-100 remained well below the critical micellar concentration for the surfactant, -0.02% (20) . A parallel titration, employing nonpretreated reactants, was performed in the presence of 0.2% Triton X-100 in the assay buffer and a fourth titration was performed in the total absence of the detergent.
Binding studies with Fab and Fcfragments. Fab and Fc fragments of the paraprotein were prepared by hydrolysis of the protein with Streptococcus sanguis IgA protease isolated as previously described by Plaut et al. (21, 22) . 15 mg of Sie IgA myeloma protein in 3 ml of PBS, pH 7.0 was incubated for 48 h with 300 Ml of the S. sanguis IgA protease preparation.
The IgA myeloma digest was dialyzed against Tris-phosphate, 0.0 15 M, pH 8.0, and chromatographed on a DEAE cellulose column (2 X 10 cm, Whatman Inc., Clifton, NJ), starting in the same buffer. Proteins were eluted with a continuous pH/salt gradient to Trisphosphate, 0.3 M, pH 4 .0. Two peaks were detected and pooled as separate fractions; these contained Fab and Fc fragments as identified by their reactions to anti-K and anti-IgA antisera (Atlantic Antibodies, Scarborough, ME) in Ouchterlony analysis (22) .
The abilities of the Fab and Fc fragments to bind LDL were assessed. A 50-zId vol of 2% BSA/Tris buffer containing either I tg of 1251-Fab or 1 Mg '251-Fc was added to 100 Mug of LDL protein in a 100-Mu vol. The samples were incubated for 18 h at 40C before the adaition of 100 gl of lipoprotein-free rabbit anti-human LDL serum in a 1:4 dilution. After an additional 6-h incubation at 40C, the samples were centrifuged, and the pellets were washed once and counted for 5 min.
The results were expressed as percentages of total counts recovered in the precipitate.
Results
Physical studies. The physical properties of the coagulum recovered from the patient's plasma (Fig. 2) made it possible to recover his coagulated immune complexes in an almost pure state upon repeated washings with PBS and low-speed centrifugation. The coagulum was readily dissociable at pH 10.8, and further purification could be achieved through a series of cycles in which the coagulum was dispersed at pH 10.8 and permitted to reaggregate at pH 6.5. The density of the solution of dispersed coagulum at pH 10.8 was increased (Fig. 3 A) (23) . This peak was preceded by a small quantity of VLDL which is heterogeneous in size.
Of interest is the absence of any HDL in this or any other fraction.
The lipoproteins isolated from the coagulum are shown in Fig. 3 (18) . Similarly extracted proteins were also isoelectrically focused on single-dimensional 7% gels with the demonstration of apo E isoforms as well as apo A-I. 2 The immunoglobulins of the coagulum were examined by immunoelectrophoresis which demonstrated reactivity only with anti-IgA and anti-K chain serum (performed at The Shand's Hospital). This paraprotein was designated Sie IgA, taking the first three letters from the name of the subject. Upon electrophoresis in 5% polyacrylamide gels in SDS (Fig.  4 A) , Sie IgA-C and Sie IgA-P each showed multiple bands with the former appearing enriched in larger molecular weight components. Upon reduction both samples resolved into two bands which migrated as expected for heavy and light chains. Fig. 3 C demonstrates the Schlieren pattern obtained during sedimentation velocity studies of Sie IgA-C demonstrating its polymeric state, the peaks sedimenting as 7, 10, and 13 S. Upon reduction a single peak is seen. By contrast, in IgA from plasma, the 7-S component was the most prominent, preceded by a large I I-S peak but no resolved 13-S material.
Sie IgA was further purified on a Sepharose 4B column to which LDL had been coupled (17) . After being adsorbed to the column, washed with saline, and eluted with pH 10.8 glycine buffer, Sie IgA-C was again shown to be polymeric with predominant 10-and 13-S species upon analytical ultracentrifugation.
Immunologic studies with Sie IgA. As an initial assessment of the immunoreactivity of Sie IgA, capillary precipitation was utilized with VLDL, LDL, and HDL from normal donors and paraprotein recovered from the coagulum (Fig. 4 B) . As Fig. 6 A. The titrations are very similar with 50% binding of the tracer achieved with -630 ng of IgA. Fig. 6 B illustrates the relative efficiency of each of the major classes of human serum lipoproteins in the displacement of '25I-LDL tracer from Sie IgA-C. Large VLDL, at a protein concentration of 1 X l0-4 g/liter, displaced 50% of '251-LDL tracer at 1.25 X l0-4 g/liter, whereas -2.5 X l0-4 g/liter of small VLDL and over 5 X l0-4 g/liter of LDL protein were required to achieve the same end. HDL Fig. 7 shows the displacement of '251-LDL from Sie IgA-C using purified apolipoproteins, the concentrations of the displacing apoproteins being expressed on a molar basis. The similar displacement with apo B and apo E was a consistent finding with many preparations of these proteins; however, because of uncertainty in the molecular weight of apo B and its aggregation in solution, the apparent identity of the displacement curves may be fortuitous. No displacement was ever observed with apo A-I or apo A-II. The reactivity of apo C with Sie IgA was examined in 11 experiments utilizing either column purified bulk apo C or apo C-Il and apo C-Ill purified by electroelution from acrylamide gels. In each case weak displacement occurred with displacement curves shifted about two orders of magnitude to the right of those for apo B and apo E. In only one case did displacement approach completion (shown in Fig. 7) .
If one calculates the difference in quantity of apo B needed to give 50% displacement using native LDL (Fig. 6) buffer ( Fig. 7) To address this question, an attempt was made to examine apo B after reconstitution within a hydrophobic environment in which it retains immunoreactivity as demonstrated with polyvalent antibodies. This can be achieved by displacing the lipids from apo B by the addition of Triton X-100 to LDL (24, 25) . In the presence of 0.2% Triton X-100 Apo B is delipidated, and its physical state is altered; however, it is virtually identical to native LDL from an immunologic standpoint (manuscript submitted for publication).
The effect of Triton X-100 on the activity of Sie IgA-C is summarized in Fig. 8 A. Triton X-100 at concentrations above the critical micellar concentration of the detergent completely (Fig. 8 B) . By contrast, similar pretreatment of the '25I-LDL tracer with the detergent sharply reduced recognition by the paraprotein. Thus, the reactive conformation of the binding site on Sie IgA appears unperturbed after exposure to supramicellar concentration of Triton X-100. By contrast, these same conditions that remove >95% of the lipid on LDL, with profound conformational changes of the protein (25) , give rise to a Triton-Apo B complex which is no longer a reactive ligand for the immunoprotein. Thus, by contrast to the persisting reactivity with polyvalent antisera, the antigenic site of Sie IgA is lost after delipidation with Triton X-100, suggesting that this site is either readily disordered or buried by the surfactant.
To examine the nature of the Sie IgA binding site on apo B, LDL was incubated with a mixture of glycosidases from Streptococcus pneumoniae to remove essentially all of its carbohydrate, preparation II (26) . This deglycosylated LDL was first tested with the Sie IgA in a capillary precipitation assay with the formation of a copious precipitate (Fig. 5 A) presumably apo E, through a site on the Fab fragment. This immunoglobulin is derived from a myeloma. IgA recognizes a common structural determinant in an apo Blike protein of all animal species tested.
Discussion
The occurrence of aggregated complexes of lipoproteins and reactive immunoglobulins of large enough size so that they can be seen circulating through blood vessels is an uncommon finding. The presence of these circulating complexes was associated with deterioration in mental function, fortunately with a return to normal mentation as the concentration of circulating complexes decreased.
The composition of the immune complex has been determined to consist of IgA reactive with an apolipoprotein B and E containing lipoproteins; thus this patient is one of a growing number of individuals with an autoimmune hyperlipidemia. The strong propensity of this subject's IgA to form stable complexes in a specific manner with VLDL, IDL, and LDL was evidenced by the huge quantity of such complexes in the patient's circulation. The polymeric state of Sie IgA-C is consistent with that found in many other IgA myelomas (27) .
The specificity of the binding of Sie IgA with apo B is independent of its carbohydrate moieties; however, lipid may play a role in fostering a favored antigen conformation for the apolipoproteins.
By contrast to its effective binding with apo B and E, there appears to be a very weak association between Sie IgA and the apo C. The nature of this affinity is unclear. Bulk apo C, apo C-II, and apo C-IlI, exhaustively purified by chromatography and electrophoresis, cause weak displacement of 1251-LDL from Sie IgA (Fig. 7) . In a further attempt to remove trace highaffinity immunoreactive fragments of apo B or apo E, apo C was passed over a Sie IgA-Sepharose 4B immunoadsorbent column that had sufficient binding capacity to remove small quantities of high-affinity contaminants in the amounts to be anticipated as judged by the total immune displacement of the apo C preparation. Nonetheless, the unbound apo C fraction retained immune displacement ability identical to Fig. 7 . Despite these precautions, it is possible that a trace contaminant may be responsible for the weak displacement activity. Alternatively, Sie IgA may recognize apo C, weakly, perhaps through a conformational determinant, or the apo C may interact with the '251I-LDL tracer to cause a loss of affinity for Sie IgA. These possibilities can not be distinguished at present. Sie IgA has antibodylike properties which were exploited in the purification protocol for the paraprotein. The purified Sie IgA-C readily bound normal large and small VLDL, IDL, and LDL and failed to bind HDL. The observation that binding of Sie IgA to LDL occurs through the Fab portion provides added justification for considering it to be an antibodylike protein. The finding that triglyceride-rich lipoproteins, both large and small, interact more strongly than LDL suggests that the paraprotein recognizes differences in apolipoprotein structure among these various lipoproteins. Whether the enhanced binding seen with VLDL solely reflects conformational differences in apo B or some synergistic enhancement of binding brought about by the presence of apo E or even the apo C is unknown. Possible reactivity with the smaller form of apo B, apo B-48, which is present in chylomicrons, has not been tested (28 IgA, apparently is a protein whose presence has only been reported in mammals. Its evolutionary relationship to apo B is conjectural, but the reactive domain seen by Sie IgA in both proteins appears in apo B at a much earlier evolutionary stage.
In concluding, it should be noted that though a number of immunoreactive paraproteins giving rise to autoimmune hyperlipidemias have been reported, in those instances where the lipoprotein ligand has been identified it has generally been a lipid, and to our knowledge this is only the second case where apo B has been specifically implicated as the reactive ligand (4). This is the only instance where a myeloma paraprotein is reactive with a domain that is common to apo B and apo E and appears to be conserved throughout the vertebrate animal kingdom. One wonders if Sie IgA may not be recognizing that site on these apoproteins which is reactive with the apo B, E receptor of the plasma membrane, and thus is conserved during evolution.
